Integrated Analysis Reveals Critical Genomic Regions in Prostate Tumor Microenvironment Associated with Clinicopathologic Phenotypes

Purpose: Recent studies suggest that tumor microenvironment (stroma) is important in carcinogenesis and progression. We sought to integrate global genomic structural and expressional alterations in prostate cancer epithelium and stroma and their association with clinicopathologic features. Experimental Design: We conducted a genome-wide LOH/allelic imbalance (AI) scan of DNA from epithelium and stroma of 116 prostate cancers. LOH/AI hot or cold spots were defined as the markers with significantly higher or lower LOH/AI frequencies compared with the average frequency for markers along the same chromosome. These data were then integrated with publicly available transcriptome data sets and our experimentally derived data. Immunohistochemistry on an independent series was used for validation. Results: Overall, we identified 43 LOH/AI hot/cold spots, 17 in epithelium and stroma (P < 0.001), 18 only in epithelium (P < 0.001), and eight only in stroma (P < 0.001). Hierarchical clustering of expression data supervised by genes within LOH/AI hot/cold spots in both epithelium and stroma accurately separated samples into normal epithelium, primary cancer, and metastatic cancer groups, which could not be achieved with data from only epithelium. Importantly, our experimental expression data of the genes within the LOH/AI hot/cold spots in stroma accurately clustered normal stroma from cancer stroma. We also identified 15 LOH/AI markers that were associated with Gleason score, which were validated functionally in each compartment by transcriptome data. Independent immunohistochemical validation of STIM2 within a stromal significant LOH marker (identified as associated with Gleason grade) confirmed its downregulation in the transition from moderate to high Gleason grade. Conclusions: Compartment-specific genomic and transcriptomic alterations accurately distinguish clinical and pathologic outcomes, suggesting new biomarkers for prognosis and targeted therapeutics. Clin Cancer Res; 18(6); 1578–87. ©2012 AACR.

[1]  E. Bilal,et al.  Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers , 2011, Cell cycle.

[2]  T. Capiod,et al.  Differential roles of STIM1, STIM2 and Orai1 in the control of cell proliferation and SOCE amplitude in HEK293 cells. , 2010, Cell calcium.

[3]  E. Smith,et al.  The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions. , 2009, Genome research.

[4]  A. Kimchi,et al.  The paradox of autophagy and its implication in cancer etiology and therapy , 2009, Apoptosis.

[5]  Jae K Lee,et al.  Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. , 2008, Cancer research.

[6]  P. Platzer,et al.  Breast-cancer stromal cells with TP53 mutations and nodal metastases. , 2007, The New England journal of medicine.

[7]  B. Pasche,et al.  Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. , 2007, Human molecular genetics.

[8]  C. Gallagher.  Extending the Linear Model With R: Generalized Linear, Mixed Effects and Nonparametric Regression Models , 2007 .

[9]  C. Eng,et al.  Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. , 2007, JAMA.

[10]  P. Platzer,et al.  Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. , 2007, JAMA.

[11]  A. Evans,et al.  Telomere attrition in isolated high-grade prostatic intraepithelial neoplasia and surrounding stroma is predictive of prostate cancer. , 2007, Neoplasia.

[12]  Tsutomu Yoshida,et al.  Early genetic instability of both epithelial and stromal cells in esophageal squamous cell carcinomas, contrasted with Barrett's adenocarcinomas , 2007, Journal of Gastroenterology.

[13]  W. Park,et al.  Mitochondrial microsatellite instability of colorectal cancer stroma , 2006, International journal of cancer.

[14]  K. Buetow,et al.  Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array , 2006, BMC Genomics.

[15]  C. Eng,et al.  Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. , 2006, American journal of human genetics.

[16]  H. Aburatani,et al.  Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. , 2006, Biochemical and biophysical research communications.

[17]  Y. Numata,et al.  Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas , 2005, Gut.

[18]  John T. Wei,et al.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.

[19]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[20]  K. Andersson.  Alpha1 adrenoceptor subtypes and bladder function. , 2005, The Journal of urology.

[21]  pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors. , 2005, The Journal of urology.

[22]  C. Plass,et al.  Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors , 2005, British Journal of Cancer.

[23]  L. Chung,et al.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. , 2005, The Journal of urology.

[24]  A. Petrovič,et al.  Cathepsin D-related Disease-free Interval in pT1 Primary Breast Carcinomas: A Pilot Study , 2005, Clinical & Experimental Metastasis.

[25]  C. Morrison,et al.  Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.

[26]  Ryan P. McCarthy,et al.  Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. , 2004, The American journal of pathology.

[27]  A. Mannermaa,et al.  Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p , 2004, International journal of cancer.

[28]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[29]  R. Paterson,et al.  Molecular genetic alterations in the laser‐capture–microdissected stroma adjacent to bladder carcinoma , 2003, Cancer.

[30]  F. Wright,et al.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. , 2003, American journal of human genetics.

[31]  Tsutomu Yoshida,et al.  Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma , 2003, British Journal of Cancer.

[32]  W. Isaacs,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .

[33]  A. Billis.  pT1 Substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of renal tumors. , 2003, International braz j urol : official journal of the Brazilian Society of Urology.

[34]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[35]  Satoshi Matsumoto,et al.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.

[36]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[37]  G. Bratthauer,et al.  Allelic Losses at 3p and 11p Are Detected in Both Epithelial and Stromal Components of Cervical Small-Cell Neuroendocrine Carcinoma , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[38]  G. Ayala,et al.  Reactive stroma in prostate cancer progression. , 2001, The Journal of urology.

[39]  S. Lemeshow,et al.  Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.

[40]  R. Hruban,et al.  ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Montgomery,et al.  すい臓癌におけるACVR1B(ALK4、1B型アクチビン受容体)遺伝子の突然変異 , 2001 .

[42]  A. Wellmann,et al.  Presence of genetic alterations in microdissected stroma of human colon and breast cancers. , 2001, Journal of molecular medicine.

[43]  G. Risbridger,et al.  The role of inhibins and activins in prostate cancer pathogenesis. , 2000, Endocrine-related cancer.

[44]  R. Sellers,et al.  Cultured stromal cells: An in vitro model of prostatic mesenchymal biology , 2000, The Prostate.

[45]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[46]  T. Okamoto,et al.  Inhibition of Nuclear Factor-κB-mediated Transcription by Association with the Amino-terminal Enhancer of Split, a Groucho-related Protein Lacking WD40 Repeats* , 2000, The Journal of Biological Chemistry.

[47]  N. Maitland,et al.  Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.

[48]  C. Croce,et al.  GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. , 1997, Cancer research.

[49]  C. Begley,et al.  Molecular cloning of a novel human gene (D11S4896E) at chromosomal region 11p15.5. , 1996, Genomics.

[50]  J. H. Schuenemeyer,et al.  Generalized Linear Models (2nd ed.) , 1992 .

[51]  P. McCullagh,et al.  Generalized Linear Models, 2nd Edn. , 1990 .